All Stories

  1. Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis
  2. Comparison of SARS-CoV-2 spike-specific IgA and IgG in nasal secretions, saliva and serum
  3. Microencapsulated IL-12 Drives Genital Tract Immune Responses to Intranasal Gonococcal Outer Membrane Vesicle Vaccine and Induces Resistance to Vaginal Infection with Diverse Strains of Neisseria gonorrhoeae
  4. Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
  5. Review of: "A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients"
  6. Immune Responses to Neisseria gonorrhoeae: Challenges and Opportunities With Respect to Pelvic Inflammatory Disease
  7. COVID-19 and mucosal immunity.
  8. Immunity to gonorrhea
  9. Historical Perspectives on Mucosal Vaccines
  10. Immunity to the gonococcus
  11. A review of the current state of developing a vaccine against gonorrhea
  12. A review of immunity in the male and female genital tracts and its role in defense against STI
  13. Editorial summarizing the current status of approaches to vaccination against gonorrhea.
  14. Generating an effective immune response against gonorrhea
  15. Novel approach to developing a vaccine against gonorrhea
  16. Immunity at the internal surfaces of the body
  17. Thinking Globally, Acting Locally: Harnessing the Immune System to Deal with Recalcitrant Pathogens
  18. Mucosal Vaccines
  19. Innate Humoral Defense Factors
  20. Microbial Evasion of IgA Functions
  21. Urogenital Tract and Mammary Gland
  22. Phylogeny and Comparative Physiology of Mucosal Immunoglobulins
  23. Biological Activities of IgA
  24. Overview
  25. Preface to the Fourth Edition
  26. Immunity to Sexually Transmitted Infections
  27. Historical Aspects of Mucosal Immunology
  28. Mucosal Immunity in the Oral Cavity, Upper Respiratory Tract, and Adjacent Areas
  29. Mucosal Immunology
  30. Intestinal Immunoglobulin A: Role in Host Defense
  31. Vaccines against gonorrhea: Current status and future challenges
  32. Identification and Characterization of Intestinal Antigen-Presenting Cells Involved in Uptake and Processing of a Nontoxic Recombinant Chimeric Mucosal Immunogen Based on Cholera Toxin Using Imaging Flow Cytometry
  33. Enhancement of Adaptive Immunity to Neisseria gonorrhoeae by Local Intravaginal Administration of Microencapsulated Interleukin 12
  34. Suppression of host adaptive immune responses by Neisseria gonorrhoeae: role of interleukin 10 and type 1 regulatory T cells
  35. Neisseria gonorrhoeae selectively suppresses the development of Th1 and Th2 cells, and enhances Th17 cell responses, through TGF-β-dependent mechanisms
  36. Contrasting Roles of IL-22 and IL-17 in Murine Genital Tract Infection by Neisseria gonorrhoeae
  37. Structure and function relationships in IgA
  38. Diversion of the Immune Response to Neisseria gonorrhoeae from Th17 to Th1/Th2 by Treatment with Anti-Transforming Growth Factor β Antibody Generates Immunological Memory and Protective Immunity
  39. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins
  40. New Concepts in Immunity to Neisseria Gonorrhoeae: Innate Responses and Suppression of Adaptive Immunity Favor the Pathogen, Not the Host
  41. Critical role of Th17 responses in a murine model of Neisseria gonorrhoeae genital infection
  42. Mucosal Decisions: Tolerance and Responsiveness at Mucosal Surfaces
  43. Tolerance and Protection against Infection in the Genital Tract
  44. In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli
  45. Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces
  46. Gonorrhea
  47. Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae
  48. Molecular heterogeneity of human IgA antibodies during an immune response
  49. Tissue distribution of lymphocytes and plasma cells and the role of the gut
  50. Terminology: nomenclature of mucosa-associated lymphoid tissue
  51. Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?
  52. Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice
  53. The A Subunit of Type IIb Enterotoxin (LT-IIb) Suppresses the Proinflammatory Potential of the B Subunit and Its Ability to Recruit and Interact with TLR2
  54. Analysis of the cellular immune response induced by Bacillus thuringiensis Cry1A toxins in mice: Effect of the hydrophobic motif from diphtheria toxin
  55. In Vitro Induction of Immunoglobulin A (IgA)- and IgM-Secreting Plasma Blasts by Cholera Toxin Depends on T-Cell Help and Is Mediated by CD154 Up-Regulation and Inhibition of Gamma Interferon Synthesis
  56. Biological Functions of IgA
  57. Mutants of Type II Heat-Labile Enterotoxin LT-IIa with Altered Ganglioside-Binding Activities and Diminished Toxicity Are Potent Mucosal Adjuvants
  58. Immunomodulation with Enterotoxins for the Generation of Secretory Immunity or Tolerance: Applications for Oral Infections
  59. Induction and recall of immune memory by mucosal immunization with a non-toxic recombinant enterotoxin-based chimeric protein
  60. Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice
  61. Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells
  62. Immunologic Uniqueness of the Genital Tract: Challenge for Vaccine Development
  63. Mucosal Adjuvant Properties of Mutant LT-IIa and LT-IIb Enterotoxins That Exhibit Altered Ganglioside-Binding Activities
  64. Toll-Like Receptor 2 Mediates Cellular Activation by the B Subunits of Type II Heat-Labile Enterotoxins
  65. Biological Activities of IgA
  66. Microbial Evasion of IgA Functions
  67. Phylogeny and Comparative Physiology of IgA
  68. Innate Humoral Defense Factors
  69. Mucosal Immunology of Sexually Transmitted Diseases
  70. The Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb and Their Respective B Pentamers Differentially Induce and Regulate Cytokine Production in Human Monocytic Cells
  71. The State of the Science of Immunization against Dental Caries
  72. Mucosal Immunity
  73. Interactions of Oral Pathogens With Toll-Like Receptors: Possible Role in Atherosclerosis
  74. Humoral immune responses to microbial infections in the genital tract
  75. Immunization for Protection of the Reproductive Tract: A Review
  76. Dependence of Bacterial Protein Adhesins on Toll-Like Receptors for Proinflammatory Cytokine Induction
  77. Identification and Characterization of a Nonimmunoglobulin Factor in Human Saliva That Inhibits Streptococcus mutans Glucosyltransferase
  78. Effect of Attenuated Salmonella enterica Serovar Typhimurium Expressing a Streptococcus mutans Antigen on Secondary Responses to the Cloned Protein
  79. Urethral Cytokine and Immune Responses inChlamydia trachomatis-Infected Males
  80. Mechanisms of Immune Tolerance to Food Antigens in Humans
  81. Intestinal Macrophages Lack CD14 and CD89 and Consequently Are Down-Regulated for LPS- and IgA-Mediated Activities
  82. Distinct Cytokine Regulation by Cholera Toxin and Type II Heat-Labile Toxins Involves Differential Regulation of CD40 Ligand on CD4+ T Cells
  83. Long-term persistence and recall of immune responses in aged mice after mucosal immunization
  84. Recombinant Antigen-Enterotoxin A2/B Chimeric Mucosal Immunogens Differentially Enhance Antibody Responses and B7-Dependent Costimulation of CD4+ T Cells
  85. Strategies of immunization against mucosal infections
  86. Generation of Female Genital Tract Antibody Responses by Local or Central (Common) Mucosal Immunization
  87. Induction of mucosal immune responses in the human genital tract
  88. A method for quantification of absolute amounts of nucleic acids by (RT)-PCR and a new mathematical model for data analysis
  89. Induction of mucosal immune responses in the human genital tract
  90. Comparative Analysis of the Mucosal Adjuvanticity of the Type II Heat-Labile Enterotoxins LT-IIa and LT-IIb
  91. Mucosal Immunity in the Genital Tract: Prospects for Vaccines Against Sexually Transmitted Diseases-A Review
  92. Intestinal IgA: novel views on its function in the defence of the largest mucosal surface
  93. Cholera Toxin B Subunit as an Immunomodulator for Mucosal Vaccine Delivery
  94. Immunity to tooth decay
  95. Cytokine and Antibody Responses in Women Infected withNeisseria gonorrhoeae:Effects of Concomitant Infections
  96. Passive and active protection against disorders of the gut
  97. Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant
  98. Nasal Lymphoid Tissue (NALT) as a Mucosal Immune Inductive Site
  99. Current options for vaccine delivery systems by mucosal routes
  100. Establishment of aStreptococcus pneumoniaenasopharyngeal colonization model in adult mice
  101. Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system
  102. IgA antibody as a non-inflammatory regulator of immunity
  103. Mucosal immunoglobulins and their contribution to defence mechanisms: an overview
  104. Intranasal Immunization of Mice with PspA (Pneumococcal Surface Protein A) Can Prevent Intranasal Carriage, Pulmonary Infection, and Sepsis with Streptococcus pneumoniae
  105. Construction and oral immunogenicity of a Salmonella typhimurium strain expressing a streptococcal adhesin linked to the A2/B subunits of cholera toxin
  106. Systemic and Mucosal Protective Immunity to Pneumococcal Surface Protein A
  107. Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue
  108. Advances in Mucosal Immunology.Jiri Mestecky , Michael W. Russell , Susan Jackson , Suzanne M. Michalek , Helena Tlaskalova-Hogenova , Jaroslav Sterzl
  109. Compartmentalization within the Common Mucosal Immune System
  110. Secretory IgA response in oral immunotherapy.
  111. Affinity and Specificity of the Interactions between Streptococcus mutans Antigen I/II and Salivary Components
  112. All Forms of Human IgA Antibodies Bound to Antigen Interfere with Complement (C3) Fixation Induced by IgG or by Antigen Alone
  113. Comparison of systemic and mucosal priming for mucosal immune responses to a bacterial protein antigen given with or coupled to cholera toxin (CT) B su
  114. Function of Mucosal Immunoglobulins
  115. Serum antibody responses to Streptococcus mutans antigens in humans systemically infected with oral streptococci
  116. Liposomes and Conjugate Vaccines for Antigen Delivery and Induction of Mucosal Immune Responses
  117. Streptococcus Mutans And The Problem of Heart Cross-Reactivity
  118. Induction of human secretory and serum immune responses: molecular properties of IgA antibodies
  119. Anti‐inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG‐mediated complement activation
  120. Complement-Fixing Properties of Human IgA Antibodies Alternative Pathway Complement Activation by Plastic-Bound, But Not Specific Antigen-Bound, IgA
  121. Interaction between surface protein antigens of Streptococcus mutans and human salivary components
  122. Serum and Salivary IgA1, IgA2, IgG and IgM Antibodies to Bacterial Antigens in Aged, Edentulous, and Normal Adults
  123. Comparative Studies of the Biological Properties of Human IgA Subclasses
  124. Role of hepatocytes in the uptake of IgA and IgA-containing immune complexes in mice
  125. Induction of the Mucosal Immune Response
  126. Striking Elevation of Serum IgA, IgA-Containing Immune Complexes, and IgA Rheumatoid Factor in Clinically Silent Dermatitis Herpetiformis
  127. Analysis of heart-reactive antibodies induced in rabbits by immunization with Streptococcus mutans
  128. IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans.
  129. Detection of Food Antigen-Specific IgA Immune Complexes in Human Sera
  130. The human IgA system: A reassessment
  131. Analysis of the hepatobiliary transport of IgA with monoclonal anti-idiotype and anti-allotype antibodies
  132. Assay of human IgA subclass antibodies in serum and secretions by means of monoclonal antibodies
  133. IgA-associated renal diseases: Antibodies to environmental antigens in sera and deposition of immunoglobulins and antigens in glomeruli
  134. Secretory IgA1 and IgA2 Responses to Environmental Antigens
  135. Evidence for a Common Mucosal Immune System in Humans
  136. Selective hepatobiliary transport of human polymeric IgA in mice
  137. SELECTIVE HEPATOBILIARY TRANSPORT OF MONOCLONAL IgG, BUT NOT IgM ANTI-IDIOTYPIC ANTIBODIES, BY IgA
  138. FUNCTION AND BIOSYNTHESIS OF POLYMERIC IgA
  139. IgA-MEDIATED HEPATOBILIARY CLEARANCE OF BACTERIAL ANTIGENS
  140. Preferential transport of IgA and IgA-immune complexes to bile compared with other external secretions
  141. Researchers insecure
  142. Role of serum IgA. Hepatobiliary transport of circulating antigen
  143. IMMUNISATION WITH A PURIFIED PROTEIN FROM STREPTOCOCCUS MUTANS AGAINST DENTAL CARIES IN RHESUS MONKEYS
  144. PASSIVE IMMUNISATION WITH SERUM AND IMMUNOGLOBULINS AGAINST DENTAL CARIES IN RHESUS MONKEYS
  145. Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c
  146. Diagnostic Significance of Antibodies in Oral Secretions